Jiangsu Lianhuan Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is SACUBITRIL VALSARTAN SODIUM, with a corresponding US DMF Number 39591.
Remarkably, this DMF maintains an Active status since its submission on February 25, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 24, 2024, and payment made on March 21, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II